ADVERTISEMENT
The U.S. Supreme Court ruled that the abortion pill Mifepristone can continue to be available by mail without requiring an in-person appointment with a clinician.
Supreme Court delivers major midterm election decision
The nation’s highest court granted emergency requests from drugmakers Danco Laboratories and GenBioPro to block the appeals court ruling.
ADVERTISEMENT